Epicore Biosystems
810 Memorial Dr 100 Cambridge, Massachusetts 02139, US
https://www.epicorebiosystems.com/
Leadership & Board
Current Number of Employees40
Current LinkedIn Followers5,639
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$38M
Total Amount Raised$38M
Total Funding Rounds2
Total Funding Rounds2
Latest Funding Amount$6M
Latest Funding Amount$6M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation―
Post-Money Valuation―
Company Momentum Positive
Articles Published on TipRanks4
Articles Published on TipRanks
4
LinkedIn Trend+0.91% followers
LinkedIn Trend
+0.91% followers
Workforce Trend+0.0% employees
Workforce Trend
+0.0% employees
Epicore Biosystems LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Company Momentum indicates whether the company is gaining or losing traction over time. This proprietary TipRanks metric analyzes changes in a company’s workforce and LinkedIn follower trends, balancing these signals together to generate an overall momentum sentiment.
Employee Trend
Epicore Biosystems had 40 employees as of April 27, 2026. The number of employees increased by 0 (0.00%) week-over-week.
40Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Epicore Biosystems had 5,639 followers as of April 27, 2026. The number of followers increased by 51 (0.91%) week-over-week.
5,639Latest Followers Count
51(0.91%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.
Main Enterprise Clients
A snapshot of major enterprise customers that use this private company’s products or services, highlighting its commercial reach and market adoption.
Funding Round
Jun 01, 2025
Series B
$6.00M
―
May 01, 2025
Series B
$32.00M
―
Investors
Series B (2)
Series B (2)
